HB 1114 Indiana House · 2026 Regular Session

Coverage for certain cancer prescriptions.

Summary
Prohibits a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization that provides coverage for advanced, metastatic cancer and associated conditions from requiring that, before providing coverage for a prescription drug, the insured fail to successfully respond to a different prescription drug or prove a history of failure of a different prescription drug.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Feb 2026
House Passage
Feb 2026
Senate Passage
Feb 2026
Signed into Law
Mar 2026
Introduced Jan 5, 2026 Signed Mar 3, 2026
Maddy AI version diff · 4 comparisons

What changed between versions

House Bill (H) House Bill (S) · 4 edits
MODERATE
The bill was amended to expand coverage eligibility from only prescription drugs to include both prescription drugs and state employee health plans (for Section 1) and accident and sickness insurance policies (for Section 2). Additionally, the effective date for these new requirements was extended from July 1, 2026, to July 1, 2027, and the definition of 'associated conditions' was updated to require that symptoms be directly attributable to cancer based on clinical evidence.
Scope change
The bill's scope was broadened to apply to state employee health plans and private accident and sickness insurance policies, in addition to prescription drugs, and the implementation timeline was delayed by one year.
ELIGIBILITY

Expanded applicability to include state employee health plans and accident and sickness insurance policies, not just prescription drugs.

TIMELINE

Delayed the effective date of the new requirements from July 1, 2026, to July 1, 2027.

DEFINITION

Updated the definition of 'associated conditions' to require that symptoms be directly attributable to cancer based on clinical evidence and generally accepted guidelines.

REQUIREMENT

Added a new requirement that plans established, entered into, amended, or renewed after June 30, 2026, must comply with the new coverage rules.

Floor votes · Senate Feb 24, 2026 · House Jan 28, 2026

How they voted

443
Passed · 2 other
Total votes 49
Feb 24, 2026
D Democratic9
8 Yea 1
88% Yea
R Republican40
36 Yea 3 Nay 1
90% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
23
Key actions
10
Committee
3
Amendments
1
Mar 3, 2026
Signed into law
Signed by the Governor
executive
Feb 27, 2026
Upper · Passed
Signed by the President of the Senate
upper
Feb 26, 2026
Upper · Passed
Signed by the President Pro Tempore
upper
Feb 25, 2026
Lower · Passed
Signed by the Speaker
lower
Feb 24, 2026
Upper · Passed
Third reading: passed; Roll Call 233: yeas 45, nays 3
upper
Feb 19, 2026
Upper · Passed
Committee report: do pass, adopted
upper
Feb 12, 2026
Upper · Passed
Committee report: do pass adopted; reassigned to Committee on Appropriations
upper
Jan 28, 2026
Lower · Passed
Third reading: passed; Roll Call 145: yeas 93, nays 0
lower
Jan 27, 2026
Lower · Passed
Amendment #1 (Pryor) prevailed; voice vote
lower
Jan 20, 2026
Lower · Passed
Committee report: do pass, adopted
lower
4 primary · 5 co-sponsors

Sponsors